Linked Life Data

7961451

Source:http://linkedlifedata.com/resource/pubmed/id/7961451

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7961451rdf:typepubmed:Citationlld:pubmed
pubmed-article:7961451lifeskim:mentionsumls-concept:C0004651lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C0205245lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C0332255lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C0017262lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C1336789lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C1883221lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C1883204lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C1998793lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C1880389lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C2911684lld:lifeskim
pubmed-article:7961451lifeskim:mentionsumls-concept:C0185117lld:lifeskim
pubmed-article:7961451pubmed:issue22lld:pubmed
pubmed-article:7961451pubmed:dateCreated1994-12-16lld:pubmed
pubmed-article:7961451pubmed:abstractTextThe repressor protein of bacteriophage 434 binds to DNA as a dimer of identical subunits. Its strong dimerization is mediated by the carboxyl-terminal domain. Cooperative interactions between the C-terminal domains of two repressor dimers bound at adjacent sites can stabilize protein-DNA complexes formed with low-affinity binding sites. We have constructed a plasmid, pCT1, which directs the overproduction of the carboxyl-terminal domain of 434 repressor. The protein encoded by this plasmid is called CT-1. Cells transformed with pCT1 are unable to be lysogenized by wild-type 434 phage, whereas control cells are lysogenized at an efficiency of 1 to 5%. The CT-1-mediated interference with lysogen formation presumably results from formation of heteromeric complexes between the phage-encoded repressor and the plasmid-encoded carboxyl-terminal domain fragment. These heteromers are unable to bind DNA and thereby inhibit the repressor's activity in promoting lysogen formation. Two lines of evidence support this conclusion. First, DNase I footprinting experiments show that at a 2:1 ratio of CT-1 to intact 434 repressor, purified CT-1 protein prevents the formation of complexes between 434 repressor and its OR1 binding site. Second, cross-linking experiments reveal that only a specific heterodimeric complex forms between CT-1 and intact 434 repressor. This latter observation indicates that CT-1 interferes with 434 repressor-operator complex formation by preventing dimerization and not by altering the conformation of the DNA-bound repressor dimer. Our other evidence is also consistent with this suggestion. We have used deletion analysis in an attempt to define the region which mediates the 434 repressor-CT-1 interaction. CT-1 proteins which have more than the last 14 amino acids removed are unable to interfere with 434 repressor action in vivo.lld:pubmed
pubmed-article:7961451pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:languageenglld:pubmed
pubmed-article:7961451pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:citationSubsetIMlld:pubmed
pubmed-article:7961451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7961451pubmed:statusMEDLINElld:pubmed
pubmed-article:7961451pubmed:monthNovlld:pubmed
pubmed-article:7961451pubmed:issn0021-9193lld:pubmed
pubmed-article:7961451pubmed:authorpubmed-author:KoudelkaG BGBlld:pubmed
pubmed-article:7961451pubmed:authorpubmed-author:CarlsonP APAlld:pubmed
pubmed-article:7961451pubmed:issnTypePrintlld:pubmed
pubmed-article:7961451pubmed:volume176lld:pubmed
pubmed-article:7961451pubmed:ownerNLMlld:pubmed
pubmed-article:7961451pubmed:authorsCompleteYlld:pubmed
pubmed-article:7961451pubmed:pagination6907-14lld:pubmed
pubmed-article:7961451pubmed:dateRevised2009-11-18lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:meshHeadingpubmed-meshheading:7961451-...lld:pubmed
pubmed-article:7961451pubmed:year1994lld:pubmed
pubmed-article:7961451pubmed:articleTitleExpression, purification, and functional characterization of the carboxyl-terminal domain fragment of bacteriophage 434 repressor.lld:pubmed
pubmed-article:7961451pubmed:affiliationDepartment of Biological Sciences, State University of New York at Buffalo 14260-1300.lld:pubmed
pubmed-article:7961451pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7961451pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:7961451pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7961451lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7961451lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7961451lld:pubmed